Advertisement

Towards optimal stopping in radiation therapy

Published:February 06, 2019DOI:https://doi.org/10.1016/j.radonc.2019.01.010

      Highlights

      • Mathematical tools can help assess treatment efficacy on the fly.
      • Balance the competition of NTCP vs. TCP dynamically.
      • Stopping may refer to transitioning to a more effective mode of treatment.
      • Optimally stop or transition, not too early, not too late.

      Abstract

      A typical fractionated radiotherapy (RT) course is a long and arduous process, demanding significant financial, physical, and mental commitments from patients. Each additional session of RT significantly increases the physical and psychological burden on patients and leads to higher radiation exposure in organs-at-risk (OAR), while, in some cases, the therapeutic benefits might not be high enough to justify the risks. Today, through technological advancements in molecular biology, imaging, and genetics more information is gathered about individual patient response before, during, and after the treatment. we highlight some of the ways that mathematical tools can help assess treatment efficacy on the fly, adapt the treatment plan based on individual biological response, and optimally stop the treatment, if necessary. We term this “Optimal Stopping in RT (OSRT)”, after a similar concept in the fields of dynamic programming and Markov decision processes. In short, OSRT can dynamically determine “whether, when and how” to stop the treatment to improve therapeutic ratios.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Radiotherapy and Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ajdari Ali
        • Ghate Archis
        • Kim Minsun
        Adaptive treatment-length optimization in spatiobiologically integrated radiotherapy.
        Phys Med Biol. 2018; 63075009
        • Baumann M.
        • Krause M.
        • Overgaard J.
        • et al.
        Radiation oncology in the era of precision medicine.
        Nat Rev Cancer. 2016; 16: 234-250
        • Ben-Tal A.
        • Goryashko A.
        • Guslitzer E.
        • et al.
        Adjustable robust solutions of uncertain linear programs.
        Math Program. 2004; 99: 351-376
        • Bogowicz M.
        • Riesterer O.
        • Stark L.S.
        • et al.
        Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.
        Acta Oncologica. 2017; 56: 1531-1536
        • Colgan R.
        • McClelland J.
        • McQuaid D.
        • et al.
        Planning lung radiotherapy using 4D CT data and a motion model.
        Phys Med Biol. 2008; 53: 5815-5830
        • Di Maio Massimo
        • Gallo Ciro
        • Leighl Natasha B.
        • Piccirillo Maria Carmela
        • Daniele Gennaro
        • Nuzzo Francesco
        • et al.
        Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials.
        J Clin Oncol. 2015; 33: 910-915
        • El Naqa Issam
        • Johansson Adam
        • Owen Dawn
        • Cuneo Kyle
        • Cao Yue
        • Matuszak Martha
        • et al.
        Modeling of normal tissue complications using imaging and biomarkers after radiation therapy for hepatocellular carcinoma.
        Int J Radiation Oncol Biol Phys. 2018; 100: 335-343
        • Falchook Aaron D.
        • Tracton Gregg
        • Stravers Lori
        • Fleming Mary E.
        • Snavely Anna C.
        • Noe Jeanne F.
        • et al.
        Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: a prospective feasibility study.
        Adv Radiat Oncol. 2016; 1: 115-121
        • Forker L.J.
        • Choudhury A.
        • Kiltie A.E.
        Biomarkers of tumour radiosensitivity and predicting benefit from radiotherapy.
        Clin Oncol. 2015; 27: 561-569
        • Gerweck Leo E
        • Vijayappa Shashirekha
        • Kurimasa Akihiro
        • et al.
        Tumor cell radiosensitivity is a major determinant of tumor response to radiation.
        Cancer Res. 2006; 66: 8352-8355
        • Hall Susan
        • Rudrawar Santosh
        • Zunk Matthew
        • et al.
        Protection against radiotherapy-induced toxicity.
        Antioxidants (Basel, Switzerland). 2016; 5
        • Holthusen H.
        Erfahrungen über die Verträglichkeitsgrenze für Röntgenstrahlen und deren Nutzanwendung zur Verhütung von Schäden.
        Strahlentherapie. 1936; 57: 254-269
        • Kong Feng-Ming
        • Ten Haken Randall K.
        • Schipper Matthew
        • et al.
        Effect of midtreatment PET/CT-adapted radiation therapy with concurrent chemotherapy in patients with locally advanced non-small-cell lung cancer.
        JAMA Oncol. 2017; 3: 1358-1365
        • Kononenko I.
        Inductive and Bayesian learning in medical diagnosis.
        Appl Artif Intell. 1993; 7: 317-337
        • Krause M.
        • Dubrovska A.
        • Linge A.
        • et al.
        Cancer stem cells: radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments.
        Adv Drug Deliv Rev. 2017; 109: 63-73
        • Lordick Florian
        • Ott Katja
        • Krause B.
        • et al.
        PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.
        Lancet Oncol. 2007; 8: 797-805
        • Lutz S.
        • Berk L.
        • Chang E.
        • et al.
        Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline.
        Int J Rad Oncol Biol Phys. 2011; 79: 965-976
        • Madani Indira
        • De Ruyck Kim
        • Goeminne Hannelore
        • et al.
        Predicting risk of radiation-induced lung injury.
        J Thoracic Oncol. 2007; 2: 864-874
        • Palmer Joshua D.
        • Zaorsky Nicholas G.
        • Witek Matthew
        • Bo Lu.
        Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer.
        J Thoracic Disease. 2014; 6: 387
        • Puterman M.L.
        Markov decision processes: discrete stochastic dynamic programming.
        Wiley-Interscience, NJ, Hoboken2014
        • Saberian Fatemeh
        • Ghate Archis
        • Kim Minsun
        A theoretical stochastic control framework for adapting radiotherapy to hypoxia.
        Phys Med Biol. 2016; 61: 7136-7161
        • Shusharina N.
        • Craft D.L.
        • Chen Y.-L.
        • et al.
        The clinical target distribution: a probabilistic alternative to the clinical target volume.
        Phys Med Biol. 2018;
        • Stenmark Matthew H.
        • Cai Xu-Wei
        • Shedden Kerby
        • Hayman James A.
        • Yuan Shuanghu
        • Ritter Timothy
        • et al.
        Combining Physical and Biologic Parameters to Predict Radiation-Induced Lung Toxicity in Patients With Non-Small-Cell Lung Cancer Treated With Definitive Radiation Therapy.
        Int J Rad Oncol, Biol, Phys. 2012; 84e217
        • Tang J.I.
        • Shakespeare T.P.
        • Lu J.J.
        • Chan Y.H.
        • Lee K.M.
        • Wong L.C.
        • et al.
        Patients’ preference for radiotherapy fractionation schedule in the palliation of symptomatic unresectable lung cancer.
        J Med Imaging Radiat Oncol. 2008; 52: 497-502
        • ten Eikelder S.C.M.
        Adjustable robust treatment-length optimization in radiation therapy. Research master thesis.
        Tilburg University, 2018
        • Thompson W.R.
        On the likelihood that one unknown probability exceeds another in view of the evidence of two samples.
        Biometrika. 1933; 25: 285
        • Tucker Susan L.
        • Li Minghuan
        • Ting Xu.
        • et al.
        Incorporating single-nucleotide polymorphisms into the lyman model to improve prediction of radiation pneumonitis.
        Int J Rad Oncol Biol Phys. 2013; 85: 251-257
        • Unkelbach J.
        • Chan T.C.Y.
        • Bortfeld T.
        Accounting for range uncertainties in the optimization of intensity modulated proton therapy.
        Phys Med Biol. 2007; 52: 2755-2773
        • Vera Pierre
        • Thureau Sébastien
        • Chaumet-Riffaud P.
        • et al.
        Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by 18 F-misonidazole PET/CT in patients with non-small cell lung carcinoma (RTEP5 Study).
        J Nucl Med. 2017; 58: 1045-1053
        • Vera-Badillo F.E.
        • Shapiro R.
        • Ocana A.
        • Amir E.
        • Tannock I.F.
        Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer.
        Ann Oncol. 2013; 24: 1238-1244
        • Wardman P.
        Chemical radiosensitizers for use in radiotherapy.
        Clin Oncol. 2007; 19: 397-417
        • Watkins C.
        • Dayan P.
        Technical Note Q,-Learning.
        Mach Learn. 1992; 8: 279-292
        • Weichselbaum Ralph R.
        • Liang Hua
        • Deng L.
        • et al.
        Radiotherapy and immunotherapy: a beneficial liaison?.
        Nat Rev Clin Oncol. 2017; 14: 365-379
        • Yue Jinbo
        • Shi Qiuling
        • Ting Xu.
        • Jeter Melenda
        • Chen Ting Yu
        • Komaki Ritsuko
        • et al.
        Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study.
        Qual Life Res. 2018; 27: 1-8